[Retracted] Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer

Table 3

Comparison of clinical efficacy.

Group	Observation group	Control group	χ ^2 index	index
	(n = 58)	(n = 58)
CR	3(5.17)	8(13.79)	—	—
PR	11(18.97)	19(32.76)	—	—
SD	27(46.55)	22(37.93)	—	—
PD	17(29.31)	9(15.52)	—	—
RR	24.14%	46.55%	0.786	0.012
DCR	70.69%	84.48%	1.023	0.005